Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases

Brian M Nguyen; Christine L Do; Ian P Boydstun; Palak B Wall

doi:10.1016/j.jaapos.2024.103901

Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases

J AAPOS. 2024 Jun;28(3):103901. doi: 10.1016/j.jaapos.2024.103901. Epub 2024 Mar 25.

Authors

Brian M Nguyen¹, Christine L Do², Ian P Boydstun³, Palak B Wall³

Affiliations

¹ Corewell (Beaumont) Health, Taylor, Michigan. Electronic address: brian.nguyen2@corewellhealth.org.
² Western University of Health Sciences COMP, Pomona, California.
³ Akron Children's Hospital, Ohio.

PMID: 38537896
DOI: 10.1016/j.jaapos.2024.103901

Abstract

We report 2 pediatric cases of iris atrophy that developed roughly 1 month after intracameral injection of dexamethasone suspension 9% following unilateral goniotomy and cataract extraction.

Published by Elsevier Inc.

Publication types

Case Reports

MeSH terms

Anterior Chamber / drug effects
Anterior Chamber / pathology
Atrophy* / chemically induced
Cataract Extraction* / adverse effects
Child
Dexamethasone* / administration & dosage
Dexamethasone* / adverse effects
Female
Glucocorticoids* / administration & dosage
Glucocorticoids* / adverse effects
Humans
Injections, Intraocular* / adverse effects
Iris Diseases / chemically induced
Iris Diseases / diagnosis
Iris* / pathology
Male
Trabeculectomy / adverse effects

Substances

Dexamethasone
Glucocorticoids